O-GlcNAcylation of ATG4B positively regulates autophagy by increasing its hydroxylase activity

Autophagy is a catabolic degradation process and maintains cellular homeostasis. And autophagy is activated in response to various stress conditions. Although O-GlcNAcylation functions a sensor for nutrient and stress, the relationship between O-GlcNAcylation and autophagy is largely unknown. Here,...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget Vol. 7; no. 35; pp. 57186 - 57196
Main Authors: Jo, Yoon Kyung, Park, Na Yeon, Park, So Jung, Kim, Byung-Gyu, Shin, Ji Hyun, Jo, Doo Sin, Bae, Dong-Jun, Suh, Young-Ah, Chang, Jeong Ho, Lee, Eun Kyung, Kim, Sang-Yeob, Kim, Jin Cheon, Cho, Dong-Hyung
Format: Journal Article
Language:English
Published: United States Impact Journals LLC 30-08-2016
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Autophagy is a catabolic degradation process and maintains cellular homeostasis. And autophagy is activated in response to various stress conditions. Although O-GlcNAcylation functions a sensor for nutrient and stress, the relationship between O-GlcNAcylation and autophagy is largely unknown. Here, we identified that ATG4B is novel target for O-GlcNAcylation under metabolic stress condition. Treatment with PugNAc, an O-GlcNAcase inhibitor increased activation of autophagy in SH-SY5Y cells. Both bimolecular fluorescence complementation and immunoprecipitation assay indicated that OGT directly interacts with ATG4B in SH-SY5Y cells. We also found that the O-GlcNAcylated ATG4B was increased in autophagy activation conditions, and down-regulation of OGT reduces O-GlcNAcylation of ATG4B under low glucose condition. Furthermore, the proteolytic activity of ATG4B for LC3 cleavage was enhanced in PugNAc-treated cells. Taken together, these results imply that O-GlcNAcylation of ATG4B regulates autophagy activation by increasing its proteolytic activity under metabolic stress condition.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1949-2553
1949-2553
DOI:10.18632/oncotarget.11083